Mind Medicine (MindMed) Inc.
One World Trade Center
Suite 8500
New York, NY 10007
United States
212-220-6633
https://www.mindmed.co
版塊: Healthcare
行業: Biotechnology
全職員工: 57
高階主管
| 名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
|---|---|---|---|---|
| Mr. Robert Barrow | CEO & Director | 956.1k | 無 | 1989 |
| Mr. Schond L. Greenway M.B.A. | Chief Financial Officer | 343.28k | 無 | 1972 |
| Dr. Daniel Rollings Karlin M.A., M.D. | Chief Medical Officer | 663.63k | 無 | 1981 |
| Dr. Miriam Halperin Wernli Ph.D. | Executive President | 552.46k | 無 | 1953 |
| Dr. Scott M. Freeman M.D. | Co-Founder & Clinical Advisor | 313.65k | 無 | 1957 |
| Mr. Leonard Latchman | Co-founder | 無 | 無 | 無 |
| Ms. Carrie F. Liao CPA, CGMA | VP & Chief Accounting Officer | 無 | 無 | 無 |
| Mr. Mark R. Sullivan J.D. | Chief Legal Officer & Corporate Secretary | 無 | 無 | 1971 |
| Dr. Francois P. Lilienthal M.B.A., M.D. | Chief Commercial Officer | 無 | 無 | 無 |
描述
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.
公司管治
截至 2024年4月1日 止，Mind Medicine (MindMed) Inc. 的 ISS 管治質素評分為 6。 Pillar 分數正在審核中：7；董事會：5；股東權利：3；現金賠償：8。
